Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)— 510(k) K260578

Substantially Equivalent

Ambu A/S

FDA 510(k) clearance K260578 for Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US), Substantially Equivalent on 2026-07-14. Applicant: Ambu A/S. Device class: 2.

Summary

Ambu's clearance covers the Neuroline Cup MRI/CT, the Neuroline Cup MRI/CT-set, and the Neuroline Cup MRI/CT-mini set, each listed in several 72704-series models. They're filed under GXY, cutaneous electrodes.

Class II, 21 CFR 882.1320. Neurology is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Ambu filed from Ballerup, Denmark. The decision came 144 calendar days after receipt (February 20 to July 14, 2026).

Clearance details

Applicant
Ambu A/S
Product code
Product code GXY
Device class
Class 2
Regulation
21 CFR 882.1320
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Ballerup, DK
Download summary PDFView on FDA.gov ↗

Recent devices under product code GXY

view all

More clearances from Ambu A/S

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.